1. A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes. Issue 2 (10th November 2022) Authors: Zeidan, Amer M.; Borate, Uma; Pollyea, Daniel A.; Brunner, Andrew M.; Roncolato, Fernando; Garcia, Jacqueline S.; Filshie, Robin; Odenike, Olatoyosi; Watson, Anne Marie; Krishnadasan, Ravitharan; Bajel, Ashish; Naqvi, Kiran; Zha, Jiuhong; Cheng, Wei‐Han; Zhou, Ying; Hoffman, David; Harb, Jason G.... Journal: American journal of hematology Issue: Volume 98:Issue 2(2023) Page Start: 272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia. Issue 5 (11th March 2021) Authors: Daver, Naval; Salhotra, Amandeep; Brandwein, Joseph M.; Podoltsev, Nikolai A.; Pollyea, Daniel A.; Jurcic, Joseph G.; Assouline, Sarit; Yee, Karen; Li, Mengsong; Pourmohamad, Tony; Samineni, Divya; Sumiyoshi, Teiko; Vaze, Anjali; Dere, Randall C.; Ma, Connie; Cooper, James Journal: American journal of hematology Issue: Volume 96:Issue 5(2021) Page Start: E175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Aldehyde dehydrogenases in acute myeloid leukemia. (March 2014) Authors: Smith, Clay; Gasparetto, Maura; Humphries, Keith; Pollyea, Daniel A.; Vasiliou, Vasilis; Jordan, Craig T. Journal: Annals of the New York Academy of Sciences Issue: Volume 1310(2014) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Beyond Survival: The US Food and Drug Administration Confirms Surrogate End Points for Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Intensive Chemotherapy. Issue 8 (10th March 2022) Authors: DiNardo, Courtney D.; Pollyea, Daniel A. Journal: Journal of clinical oncology Issue: Volume 40:Issue 8(2022) Page Start: 811 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series. Issue 4 (2nd April 2016) Authors: Stevens, Brett; Maxson, Julia; Tyner, Jeffrey; Smith, Clayton A.; Gutman, Jonathan A.; Robinson, William; Jordan, Craig T.; Lee, Choon-Kee; Swisshelm, Karen; Tobin, Jennifer; Wei, Qi; Schowinsky, Jeffrey; Rinella, Sean; Lee, Hea Gie; Pollyea, Daniel A. Journal: Leukemia & lymphoma Issue: Volume 57:Issue 4(2016:Apr.) Page Start: 927 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry. Issue 1 (30th June 2020) Authors: Pollyea, Daniel A.; George, Tracy I.; Abedi, Mehrdad; Bejar, Rafael; Cogle, Christopher R.; Foucar, Kathryn; Garcia‐Manero, Guillermo; Grinblatt, David L.; Komrokji, Rami S.; Maciejewski, Jaroslaw P.; Revicki, Dennis A.; Roboz, Gail J.; Savona, Michael R.; Scott, Bart L.; Sekeres, Mikkael A.; Tho... Journal: EJHaem Issue: Volume 1:Issue 1(2020) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry. Issue 1 (30th June 2020) Authors: Pollyea, Daniel A.; George, Tracy I.; Abedi, Mehrdad; Bejar, Rafael; Cogle, Christopher R.; Foucar, Kathryn; Garcia‐Manero, Guillermo; Grinblatt, David L.; Komrokji, Rami S.; Maciejewski, Jaroslaw P.; Revicki, Dennis A.; Roboz, Gail J.; Savona, Michael R.; Scott, Bart L.; Sekeres, Mikkael A.; Tho... Journal: EJHaem Issue: Volume 1:Issue 1(2020) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry. Issue 1 (30th June 2020) Authors: Pollyea, Daniel A.; George, Tracy I.; Abedi, Mehrdad; Bejar, Rafael; Cogle, Christopher R.; Foucar, Kathryn; Garcia‐Manero, Guillermo; Grinblatt, David L.; Komrokji, Rami S.; Maciejewski, Jaroslaw P.; Revicki, Dennis A.; Roboz, Gail J.; Savona, Michael R.; Scott, Bart L.; Sekeres, Mikkael A.; Tho... Journal: EJHaem Issue: Volume 1:Issue 1(2020) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results. Issue 11 (9th September 2018) Authors: Cortes, Jorge E.; Douglas Smith, B.; Wang, Eunice S.; Merchant, Akil; Oehler, Vivian G.; Arellano, Martha; DeAngelo, Daniel J.; Pollyea, Daniel A.; Sekeres, Mikkael A.; Robak, Tadeusz; Ma, Weidong Wendy; Zeremski, Mirjana; Naveed Shaik, M.; Douglas Laird, A.; O'Connell, Ashleigh; Chan, Geoffrey; ... Journal: American journal of hematology Issue: Volume 93:Issue 11(2018:Nov.) Page Start: 1301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Hypomethylating agents with venetoclax: have we discovered the holy grail?. Issue 2 (March 2020) Authors: Gutman, Jonathan A.; Pollyea, Daniel A. Journal: Current opinion in hematology Issue: Volume 27:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗